VERIGRAFT’s leading global position in regenerative medicine and tissue engineering was recently confirmed when our CEO, Petter Björquist, served as co-author of the Alliance for Regenerative Medicine’s latest industry briefing: Tissue Therapeutics – The Curative Potential of Combining Cells & Biomaterials.
This highlights the current state of this cutting-edge industry, explaining what Tissue Therapeutics (the products) and Tissue Engineering (the method) are all about. The article was made possible thanks to the excellent the collaboration within ARM’s Tissue Engineering Advisory Group, including Eric Roos, Caralynn Nowinski Collens, Natalie Fekete, Jordan Lancaster, Jane Lebkowski, Tom Lowery, Blair McNeill, Jeff Ross, Ph.D., and Nina Tandon, Ph.D./MBA.
Take a moment to read and reflect – and see how VERIGRAFT and our P-TEV are now recognized among the elite in this field.
Read the full report here: https://alliancerm.org/tissue-therapeutics-report/